Blood & Cancer
News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:46
- Mas informaciones
Informações:
Sinopsis
Blood & Cancer News Stories: Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest: https://bit.ly/2JlP2FN HCC rates slow in cities, continue to climb in rural areas: https://bit.ly/2Jx6Ux1 Risk factors for severe immune-related AEs identified: https://bit.ly/3fO6Fd8 Contact Blood & Cancer at podcasts@mdedge.com
